Crabel Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-148,692
Closed -$7.68M 112
2022
Q3
$7.68M Buy
+148,692
New +$6.15M 4.49% 3

Other funds holding CCXI

Crabel Capital Management's CCXI Position: Q4 2022 in Review

Crabel Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 148,692 shares — an estimated $7.68M sold.

Crabel Capital Management first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $7.68M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Crabel Capital Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Crabel Capital Management sold 148,692 ChemoCentryx, Inc. shares in Q4 2022, an estimated $7.68M.
  • Crabel Capital Management first reported a position in ChemoCentryx, Inc. in Q3 2022 and held it in 1 quarter.
  • Crabel Capital Management's ChemoCentryx, Inc. position peaked at $7.68M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Crabel Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.